Thermo Fisher Scientific introduces sequencing platform for clinical labs
Cancers | Free Full-Text | Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
ECCMID 2022 Resource Center | Thermo Fisher Scientific - UK
ECCMID 2022 Resource Center | Thermo Fisher Scientific - UK
Because science can't wait
Accessible In-House NGS with the Genexus System
Genetic Analysis Solutions | Fisher Healthcare
Because science can't wait
Thermo Fisher Scientific and AstraZeneca to Co-Develop NGS-based Companion Diagnostics
Oncomine Precision Assay Analytical Performance at Global Laboratories
Product and Application Updates | Thermo Fisher Scientific
Thermo Fisher and AstraZeneca partner to create companion diagnostics
Thermo Fisher Scientific and AstraZeneca partner for new CDx test
Drew Buskirk posted on LinkedIn
Drew Buskirk posted on LinkedIn
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
Thermo Fisher acquires Mesa Biotech in $450M tuck-in deal | 2021-01-19 | BioWorld
Omicron variant identified in less than 24 hours with the Ion AmpliSeq SARS-CoV-2 Insight Research Assay - Behind the Bench
Oncomine Precision Assay Analytical Performance at Global Laboratories
Thermo Fisher's pricision assay received breakthrough device designation
Thermo Fisher rolls out two new reproductive health assays
Setting up in a lockdown - Behind the Bench
Thermo Fisher Scientific Introduces First Next-Generation Sequencing Platform That Delivers Specimen to Report in a Single Day
Laboratory News from Lab Bulletin
Expanding Africa's genomic surveillance of SARS-CoV-2 variants - Behind the Bench
